Myomo (NYSEAMERICAN:MYO) is scheduled to be releasing its earnings data after the market closes on Monday, November 5th. Analysts expect Myomo to post earnings of ($0.20) per share for the quarter.
Myomo (NYSEAMERICAN:MYO) last posted its quarterly earnings results on Tuesday, August 7th. The company reported ($0.21) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.19) by ($0.02). The firm had revenue of $0.63 million during the quarter, compared to analysts’ expectations of $0.62 million.
Myomo stock opened at $2.16 on Friday. Myomo has a one year low of $1.60 and a one year high of $11.40.
Myomo Company Profile
Myomo, Inc, a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury.
Recommended Story: How Do You Calculate Return on Investment (ROI)?
Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with MarketBeat.com's FREE daily email newsletter.